JPS60184011A - 免疫調節剤 - Google Patents

免疫調節剤

Info

Publication number
JPS60184011A
JPS60184011A JP3866684A JP3866684A JPS60184011A JP S60184011 A JPS60184011 A JP S60184011A JP 3866684 A JP3866684 A JP 3866684A JP 3866684 A JP3866684 A JP 3866684A JP S60184011 A JPS60184011 A JP S60184011A
Authority
JP
Japan
Prior art keywords
lipoic acid
effect
response
acid
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3866684A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0475205B2 (enrdf_load_stackoverflow
Inventor
Hitoshi Omori
大森　斉
Toshihiko Yamaguchi
敏彦 山口
Itaru Yamamoto
格 山本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Toatsu Chemicals Inc
Original Assignee
Mitsui Toatsu Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Toatsu Chemicals Inc filed Critical Mitsui Toatsu Chemicals Inc
Priority to JP3866684A priority Critical patent/JPS60184011A/ja
Publication of JPS60184011A publication Critical patent/JPS60184011A/ja
Publication of JPH0475205B2 publication Critical patent/JPH0475205B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
JP3866684A 1984-03-02 1984-03-02 免疫調節剤 Granted JPS60184011A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3866684A JPS60184011A (ja) 1984-03-02 1984-03-02 免疫調節剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3866684A JPS60184011A (ja) 1984-03-02 1984-03-02 免疫調節剤

Publications (2)

Publication Number Publication Date
JPS60184011A true JPS60184011A (ja) 1985-09-19
JPH0475205B2 JPH0475205B2 (enrdf_load_stackoverflow) 1992-11-30

Family

ID=12531590

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3866684A Granted JPS60184011A (ja) 1984-03-02 1984-03-02 免疫調節剤

Country Status (1)

Country Link
JP (1) JPS60184011A (enrdf_load_stackoverflow)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4035456A1 (de) * 1989-11-09 1991-05-16 Asta Pharma Ag Arzneimittel, welche als wirkstoff schwefel enthaltende carbonsaeuren enthalten sowie deren verwendung zur bekaempfung von retroviren
US5043328A (en) * 1986-05-09 1991-08-27 Hoechst Aktiengesellschaft Formulations containing unsaturated fatty acids for the synthesis of prostaglandins and hydroxy-fatty acids in biological systems
US5569670A (en) * 1992-06-05 1996-10-29 Asta Medica Aktiengesellschaft Combination medications containing alpha-lipoic acid and related
US5728735A (en) * 1989-11-09 1998-03-17 Asta Pharma Aktiengesellschaft Pharmaceutical composition containing R-α-lipoic acid or S-α-lipoic acid as active ingredient
US6191162B1 (en) 1998-05-28 2001-02-20 Medical Research Institute Method of reducing serum glucose levels
US6197340B1 (en) 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
JP2009048818A (ja) * 2007-08-16 2009-03-05 Hitachi Cable Ltd 複合ケーブル
US7579020B2 (en) 1998-05-28 2009-08-25 Medical Research Institute Controlled release arginine α-ketoglutarate
JP2012511933A (ja) * 2008-12-16 2012-05-31 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 愛玩動物において抗ウイルス性免疫を増強する際に使用するための、抗酸化剤を含有する食物組成物
JP2012511932A (ja) * 2008-12-16 2012-05-31 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 愛玩動物において抗ウイルス性免疫を増強する際に使用するための、抗酸化剤を含有する食物組成物

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5043328A (en) * 1986-05-09 1991-08-27 Hoechst Aktiengesellschaft Formulations containing unsaturated fatty acids for the synthesis of prostaglandins and hydroxy-fatty acids in biological systems
US5334612A (en) * 1988-11-09 1994-08-02 Asta Pharma Aktiengesellschaft Pharmaceutical compositions containing as active substance sulphur-containing carboxylic acids and their use in combating retroviruses
US6271254B1 (en) 1989-11-09 2001-08-07 Asta Pharma Aktiengesellschaft Pharmaceutical compositions containing R-α-lipoic acid or S-α-lipoic acid as active ingredient
BE1005018A3 (fr) * 1989-11-09 1993-03-23 Asta Medica Ag Medicaments qui contiennent, comme substance active, des acides carboxyliques contenant du soufre, ainsi que leur utilisation pour lutter contre des retrovirus.
GR1001503B (el) * 1989-11-09 1994-02-28 Asta Pharma Ag Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
US5728735A (en) * 1989-11-09 1998-03-17 Asta Pharma Aktiengesellschaft Pharmaceutical composition containing R-α-lipoic acid or S-α-lipoic acid as active ingredient
AT500684B1 (de) * 1989-11-09 2006-10-15 Meda Pharma Gmbh & Co Kg Verwendung von schwefelhältigen carbonsäuren zur herstellung eines arzneimittels zur bekämpfung von erkrankungen durch retroviren
DE4035456A1 (de) * 1989-11-09 1991-05-16 Asta Pharma Ag Arzneimittel, welche als wirkstoff schwefel enthaltende carbonsaeuren enthalten sowie deren verwendung zur bekaempfung von retroviren
US5569670A (en) * 1992-06-05 1996-10-29 Asta Medica Aktiengesellschaft Combination medications containing alpha-lipoic acid and related
US6197340B1 (en) 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
US7118762B2 (en) 1998-05-28 2006-10-10 Medical Research Institute Controlled release lipoic acid
US6191162B1 (en) 1998-05-28 2001-02-20 Medical Research Institute Method of reducing serum glucose levels
US7579020B2 (en) 1998-05-28 2009-08-25 Medical Research Institute Controlled release arginine α-ketoglutarate
JP2009048818A (ja) * 2007-08-16 2009-03-05 Hitachi Cable Ltd 複合ケーブル
JP2012511933A (ja) * 2008-12-16 2012-05-31 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 愛玩動物において抗ウイルス性免疫を増強する際に使用するための、抗酸化剤を含有する食物組成物
JP2012511932A (ja) * 2008-12-16 2012-05-31 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 愛玩動物において抗ウイルス性免疫を増強する際に使用するための、抗酸化剤を含有する食物組成物

Also Published As

Publication number Publication date
JPH0475205B2 (enrdf_load_stackoverflow) 1992-11-30

Similar Documents

Publication Publication Date Title
KR100638684B1 (ko) 말초 혈관 질환의 치료를 위한 9-데옥시-2',9-알파-메타노-3-옥사-4,5,6-트리노르-3,7-(1',3'-인터페닐렌)-13,14-디하이드로-프로스타글란딘 에프1의 용도
EP0694307B1 (en) Atopic disease remedy
US20060173011A1 (en) Treatment of inflammatory disorders with praziquantel
JPS60184011A (ja) 免疫調節剤
US3928580A (en) Injectable glycoproteins containing terminal {37 C{38 {0 ends of human immunoglobulins
EP0554887A1 (en) The use of mammalian liver extract for the manufacture of a medicament to treat presenile or senile dementia
US5491150A (en) Supplementary therpeutic agents for the treatment of immunodeficiency syndrome
Fazekas et al. Convulsant action of phenothiazine derivatives
JPH08512311A (ja) 慢性疲労症候群治療用ヒ素医薬
US4568543A (en) Pharmaceutical composition containing a fibrinolytic agent and a diffusion factor, useful for the treatment of myocardial infarction
JPH04234320A (ja) 抗ｈｂｖ剤
ATE92756T1 (de) Mittel zur behandlung von keratose.
Alergant Treatment of gonorrhoea with amoxycillin
US6395717B1 (en) Therapeutic drug for endotoxin blood symptom and multi-organ failure induced thereby
JPS63179832A (ja) 炎症性関節疾患の治療のための医薬組成物
Clarke et al. Confusion and paranoia associated with oral tocainide
JPH029600B2 (enrdf_load_stackoverflow)
JPH05504130A (ja) 腫瘍壊死因子拮抗剤
JPS60184012A (ja) 免疫調整剤
CN101766563A (zh) 一种水溶性维生素注射剂与氯化钠注射液的配合使用方法
WO1995008334A1 (en) Antimalarial
SU1194418A1 (ru) Способ лечени детей с острой гнойной деструктивной пневмонией
JPH0251405B2 (enrdf_load_stackoverflow)
JPH0326171B2 (enrdf_load_stackoverflow)
JPS5859960A (ja) ウレイレンビス〔（置換又は未置換フエニレンカルボニルイミノ）ビス（置換ナフタレンスルホン酸）〕類